RxDoctor Payments Data

Randall Henderson, DO

Family Medicine · Whitney, TXNPI 1700879848

Payments from drug & device makers

$12,816in general payments, 2019–2025

Across 814 payments — averaging $15.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$2K
  • Novo Nordisk$1K
  • Lilly USA, LLC$1K
  • AbbVie$939
  • GSK$844
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$656
  • plus $6K from 47 others

What the payments were for

  • Food & beverage$12,795100%
  • Education$200%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$12,816 in reported general payments places this provider in the 95th percentile of 8,760 family medicine providers in Texas.

See all family medicine providers in Texas

Medicare billing

Part B allowed, 2024
$6,306
Medicare patients
169
Services billed
317

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide344$396,137
EliquisApixaban349$274,176
MounjaroTirzepatide146$185,892
JardianceEmpagliflozin129$110,345
FarxigaDapagliflozin Propanediol121$106,303
Trelegy ElliptaFluticasone/Umeclidin/Vilanter114$92,202
TrulicityDulaglutide69$88,647
XareltoRivaroxaban85$75,829
EntrestoSacubitril/Valsartan69$52,730
Breztri AerosphereBudesonide/Glycopyr/Formoterol68$49,497
JanuviaSitagliptin Phosphate49$41,836
MyrbetriqMirabegron70$33,347
VascepaIcosapent Ethyl64$31,805
TrintellixVortioxetine Hydrobromide43$31,053
Janumet XrSitagliptin Phos/Metformin Hcl30$21,480

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Wegovy$1,272$412,239356 claims
PfizerEliquis, Abrysvo$567$283,004378 claims
Lilly USA, LLCMounjaro, Trulicity$1,050$274,539215 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort, Bevespi Aerosphere$1,768$183,868271 claims
Boehringer IngelheimJardiance, Combivent Respimat, Synjardy$530$145,778180 claims
GSKTrelegy Ellipta, Breo Ellipta, Shingrix, Anoro Ellipta$844$144,161259 claims
MerckJanuvia, Janumet Xr, Janumet$329$80,03597 claims
Johnson & JohnsonXarelto$115$75,82985 claims
NovartisEntresto$175$52,73069 claims
Astellas Pharma US IncMyrbetriq$98$33,34770 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$257$31,05343 claims
Sanofi-aventis U.S. LLCSoliqua 100-33$134$16,76512 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 8,760 family medicine providers in Texas.

Other family medicine in Whitney

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →